ES2059947T3 - Preparados inyectables que contienen cefalosporina y utilizacion de los mismos. - Google Patents

Preparados inyectables que contienen cefalosporina y utilizacion de los mismos.

Info

Publication number
ES2059947T3
ES2059947T3 ES90118682T ES90118682T ES2059947T3 ES 2059947 T3 ES2059947 T3 ES 2059947T3 ES 90118682 T ES90118682 T ES 90118682T ES 90118682 T ES90118682 T ES 90118682T ES 2059947 T3 ES2059947 T3 ES 2059947T3
Authority
ES
Spain
Prior art keywords
cephalosporin
salt
preparations containing
injectable preparations
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90118682T
Other languages
English (en)
Inventor
Yasuo Ishibashi
Isamu Hasegawa
Masanori Kayano
Ryoichi Machida
Masahiro Kawahara
Sumio Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of ES2059947T3 publication Critical patent/ES2059947T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Abstract

SE DESCUBRE UNA PREPARACION QUE CONTIENE UN MEDICAMENTO CEFALOSPORINA. LA PREPARACION COMPRENDE UN DERIVADO DE CEFALOSPORINA REPRESENTADO POR LA SIGUIENTE FORMULA: NOMINALMENTE, 7(BETA)-[2-(5-AMINO-1,2,4-TIADIAZOL-3-ILO)-(Z)-2-FLUOROMETOXIIMINOACETAMIDO]-3-[(E)-3-(CARBAMOILMETILLOETILOAMONIO)-1-PROPENO-1-ILO]-3-CEFEN-4-CARBOXILATOS O UNA SAL FARMACEUTICAMENTE ACEPTABLE DE ELLOS, LACTOSA, ACIDO CITRICO O UNA SAL SODICA DE ELLA, Y ARGININA O UN HIDROCLORURO DE ELLA; O EL DERIVADO CEFALOSPORINA REPRESENTADO POR LA FORMULA (I) O UNA SAL FARMACEUTICAMENTE ACEPTABLE DE ELLA, LACTOSA, ACIDO CITRICO O UNA SAL SODICA DE ELLA, Y CLORURO SODICO. ESTA PREPARACION SE PUEDE USAR PARA PREPARAR UN MEDICAMENTO.
ES90118682T 1989-09-30 1990-09-28 Preparados inyectables que contienen cefalosporina y utilizacion de los mismos. Expired - Lifetime ES2059947T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25378289 1989-09-30

Publications (1)

Publication Number Publication Date
ES2059947T3 true ES2059947T3 (es) 1994-11-16

Family

ID=17256076

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90118682T Expired - Lifetime ES2059947T3 (es) 1989-09-30 1990-09-28 Preparados inyectables que contienen cefalosporina y utilizacion de los mismos.

Country Status (10)

Country Link
US (1) US5254545A (es)
EP (1) EP0421297B1 (es)
JP (1) JP3129428B2 (es)
KR (1) KR950013760B1 (es)
CN (1) CN1046632C (es)
AT (1) ATE97810T1 (es)
CA (1) CA2026516C (es)
DE (1) DE69004921T2 (es)
DK (1) DK0421297T3 (es)
ES (1) ES2059947T3 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0840907A (ja) * 1994-08-03 1996-02-13 Meiji Seika Kaisha Ltd セファロスポリン注射剤
US5721229A (en) * 1995-12-26 1998-02-24 Veterinary Pharmacy Corporation Soluble forms of cephalosporins and treatment of animals
UA80095C2 (en) * 2001-07-20 2007-08-27 Lilly Co Eli 2 methyl-thieno-benzodiazepine lyophilized formulation and method for the preparation thereof
EP1656930A1 (en) * 2004-11-10 2006-05-17 Basilea Pharmaceutica AG Stabilized freeze-dried formulation for cephalosporin derivatives
WO2009039324A1 (en) * 2007-09-21 2009-03-26 Forest Laboratories Holdings Limited Soluble dosage forms containing cephem derivatives suitable for parenteral administration
CN103860563B (zh) * 2012-12-18 2016-07-06 四川科伦药业股份有限公司 含头孢妥仑钠的药物组合物
CN103860484B (zh) * 2012-12-18 2016-08-24 四川科伦药业股份有限公司 注射用头孢妥仑钠冻干制剂及其制备方法
TWI608845B (zh) 2013-03-13 2017-12-21 施萬生物製藥抗生素Ip有限責任公司 抗生素化合物之鹽酸鹽
AU2014227660B2 (en) * 2013-03-15 2014-11-06 Merck Sharp & Dohme Llc Ceftolozane antibiotic compositions
US20150094293A1 (en) * 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
EP3189841B1 (en) * 2014-09-04 2023-11-22 Shionogi & Co., Ltd. Pharmaceutical preparation comprising cephalosporin having catechol groups

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2690009B2 (ja) * 1986-07-10 1997-12-10 エーザイ 株式会社 セフアロスポリン注射剤
IL84128A (en) * 1986-10-13 1992-12-01 Eisai Co Ltd 3-propenylcephem derivatives, their preparation and pharmaceutical compositions containing them
EP0612751A3 (en) * 1988-03-16 1994-09-21 Eisai Co Ltd Compounds for the preparation of cephem derivatives.

Also Published As

Publication number Publication date
ATE97810T1 (de) 1993-12-15
JP3129428B2 (ja) 2001-01-29
DK0421297T3 (da) 1994-01-17
CN1050501A (zh) 1991-04-10
US5254545A (en) 1993-10-19
CA2026516A1 (en) 1991-03-31
KR910005871A (ko) 1991-04-27
JPH03173822A (ja) 1991-07-29
DE69004921D1 (de) 1994-01-13
CN1046632C (zh) 1999-11-24
EP0421297A2 (en) 1991-04-10
EP0421297A3 (en) 1991-06-12
DE69004921T2 (de) 1994-05-05
CA2026516C (en) 1998-02-17
KR950013760B1 (ko) 1995-11-15
EP0421297B1 (en) 1993-12-01

Similar Documents

Publication Publication Date Title
ATE104971T1 (de) 2-aminopyrimidinon-derivate.
CA2039056A1 (en) 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
ES2059947T3 (es) Preparados inyectables que contienen cefalosporina y utilizacion de los mismos.
BR9503536A (pt) Composto processo para sua preparação seu uso e composição farmacêutica
EP0353821A3 (en) Antipsychotic 3-piperazinyl-benzazole derivatives
ES2045067T3 (es) Procedimiento para preparar nuevos compuestos de tiazol.
PH25532A (en) Novel n-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives, pharm,aceutical composition containing said compound, method of use thereof
HK116795A (en) Derivatives of penciclovir for the treatment of hepatitis-B infections
DK424888D0 (da) Naphthothiazepinderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende saadanne derivater
ZA912589B (en) A therapeutic agent for dysuria comprising alpha-phenyl-alpha-pyridylalkanoic acid derivatives
ES2004255A6 (es) Procedimiento de preparar compuestos del tipo de las piracinas y analogos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 421297

Country of ref document: ES